參考資料: 1. Subcommittee AAoOBaCS. Section 3: Clinical Optics. San Francisco, CA: American Academy of Ophthalmology, 2014.
2. Uptodate: Visual impairment in adults: Refractive disorders and presbyopia
3. Uptodate:Refractive errors in children
4. THE IMPACT OF MYOPIA AND HIGH MYOPIA University of New South Wales, Sydney, Australia 16–18 March 2015
5. 2010 年度全國調查研究「台灣地區6-18歲屈光狀況之流行病學」
6. Myopia Control: A Review Eye & Contact Lens 2016
7. Singapore Chinese children. Ophthalmology. 2002; 109:2065–71.
8. Chua WH, Balakrishnan V, Chan YH, et al. Atropine for the treatment of childhood myopia. Ophthalmology. 2006; 113:2285–91.
9. Chia A, Chua WH, Cheung YB, et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (ATOM2). Ophthalmology 2012;119:347–54.
10. Chia A, Chua WH, Li W, et al. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5% (ATOM2). Am J Ophthalmol 2014;157:451–7.
11. Chia A, Lu QS, Tan D. Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2: Myopia Control with Atropine 0.01% Eyedrops . Ophthalmology. 2016 Feb;123(2):391-9
12. Cheng D, Woo GC, Drobe B, Schmid KL. Effect of bifocal and prismatic bifocal spectacles on myopia progression in children: three-year results of a randomized clinical trial. JAMA Ophthalmol. 2014 Mar;132(3):258-64.
13. Charm J, Cho P. High myopia-partial reduction ortho-k: a 2-year randomized study. Optom Vis Sci. 2013;90(6):530–9.
14. Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012;53(11):7077–85.